Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 119 entries
Sorted by: Best Match Show Resources per page
From stereotype threat to stereotype threats: Implications of a multi-threat framework for causes, moderators, mediators, consequences, and interventions

stereotype threat

Neuberg SL, Shapiro JR.
GSID: thtzoN28ACkJ
JR Shapiro, SL Neuberg - Personality and Social …, 2007 - journals.sagepub.com

… the construct of stereotype threat and its implications. However, stereotype threat seems to … Complementing existing models, the authors posit a Multi-Threat Framework in which six …

Cite
SHAPIRO, Jenessa R. et NEUBERG, Steven L. From stereotype threat to stereotype threats: Implications of a multi-threat framework for causes, moderators, mediators, consequences, and interventions. Personality and Social Psychology Review, 2007, vol. 11, no 2, p. 107-130.
Shapiro, J. R., & Neuberg, S. L. (2007). From stereotype threat to stereotype threats: Implications of a multi-threat framework for causes, moderators, mediators, consequences, and interventions. Personality and Social Psychology Review, 11(2), 107-130.
Copy Download .nbib Format: MLA
Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286).

American journal of therapeutics

Einzig AI, Neuberg D, Wiernik PH, Grochow LB, Ramirez G, O'Dwyer PJ, Petrelli NJ.
PMID: 11862233
Am J Ther. 1996 Nov;3(11):750-754. doi: 10.1097/00045391-199611000-00003.

Paclitaxel was administered as a 24-h continuous infusion at 250 mg/m(2) in this Phase II trial in patients with adenocarcinoma of the colon or rectum. Nineteen patients were evaluated for toxity and 15 were assessable for response. There were...

Cite
Einzig AI, Neuberg D, Wiernik PH, et al. Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286). Am J Ther. 1996;3(11):750-754doi: 10.1097/00045391-199611000-00003.
Einzig, A. I., Neuberg, D., Wiernik, P. H., Grochow, L. B., Ramirez, G., O'Dwyer, P. J., & Petrelli, N. J. (1996). Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286). American journal of therapeutics, 3(11), 750-754. https://doi.org/10.1097/00045391-199611000-00003
Einzig, Avi I., et al. "Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286)." American journal of therapeutics vol. 3,11 (1996): 750-754. doi: https://doi.org/10.1097/00045391-199611000-00003
Einzig AI, Neuberg D, Wiernik PH, Grochow LB, Ramirez G, O'Dwyer PJ, Petrelli NJ. Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286). Am J Ther. 1996 Nov;3(11):750-754. doi: 10.1097/00045391-199611000-00003. PMID: 11862233.
Copy Download .nbib Format: NLM
Present Status of the Problem of Sugar Fermentation.

Journal of bacteriology

Neuberg C, Kobel M.
PMID: 16559759
J Bacteriol. 1934 Nov;28(5):461-71. doi: 10.1128/jb.28.5.461-471.1934.

No abstract available.

Cite
Neuberg C, Kobel M. Present Status of the Problem of Sugar Fermentation. J Bacteriol. 1934;28(5):461-71doi: 10.1128/jb.28.5.461-471.1934.
Neuberg, C., & Kobel, M. (1934). Present Status of the Problem of Sugar Fermentation. Journal of bacteriology, 28(5), 461-71. https://doi.org/10.1128/jb.28.5.461-471.1934
Neuberg, C, and Kobel, M. "Present Status of the Problem of Sugar Fermentation." Journal of bacteriology vol. 28,5 (1934): 461-71. doi: https://doi.org/10.1128/jb.28.5.461-471.1934
Neuberg C, Kobel M. Present Status of the Problem of Sugar Fermentation. J Bacteriol. 1934 Nov;28(5):461-71. doi: 10.1128/jb.28.5.461-471.1934. PMID: 16559759; PMCID: PMC533692.
Copy Download .nbib Format: NLM
Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smears.

Diagnostic pathology

Shidham VB, Komorowski R, Neuberg M, Walker A, Campbell BH, Chang CC, Dzwierzynski WW.
PMID: 16999866
Diagn Pathol. 2006 Sep 25;1:32. doi: 10.1186/1746-1596-1-32.

BACKGROUND: Sentinel lymph node (SLN) biopsy is performed at many institutions and is considered a standard of care in the management of cutaneous melanoma. The discriminatory immunostaining pattern with the 'MCW Melanoma Cocktail' (a mixture of MART-1 {1:500}, Melan-...

Cite
Shidham VB, Komorowski R, Neuberg M, et al. Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smears. Diagn Pathol. 2006;1:32doi: 10.1186/1746-1596-1-32.
Shidham, V. B., Komorowski, R., Neuberg, M., Walker, A., Campbell, B. H., Chang, C. C., & Dzwierzynski, W. W. (2006). Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smears. Diagnostic pathology, 132. https://doi.org/10.1186/1746-1596-1-32
Shidham, Vinod B, et al. "Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smears." Diagnostic pathology vol. 1 (2006): 32. doi: https://doi.org/10.1186/1746-1596-1-32
Shidham VB, Komorowski R, Neuberg M, Walker A, Campbell BH, Chang CC, Dzwierzynski WW. Prevention of an additional surgery for regional lymphadenectomy in melanoma: rapid intraoperative immunostaining of sentinel lymph node imprint smears. Diagn Pathol. 2006 Sep 25;1:32. doi: 10.1186/1746-1596-1-32. PMID: 16999866; PMCID: PMC1592125.
Copy Download .nbib Format: NLM
Geophysics. Monitoring volcanoes.

Science (New York, N.Y.)

Sparks RS, Biggs J, Neuberg JW.
PMID: 22422969
Science. 2012 Mar 16;335(6074):1310-1. doi: 10.1126/science.1219485.

No abstract available.

Cite
Sparks RS, Biggs J, Neuberg JW. Geophysics. Monitoring volcanoes. Science. 2012;335(6074):1310-1doi: 10.1126/science.1219485.
Sparks, R. S., Biggs, J., & Neuberg, J. W. (2012). Geophysics. Monitoring volcanoes. Science (New York, N.Y.), 335(6074), 1310-1. https://doi.org/10.1126/science.1219485
Sparks, R S J, et al. "Geophysics. Monitoring volcanoes." Science (New York, N.Y.) vol. 335,6074 (2012): 1310-1. doi: https://doi.org/10.1126/science.1219485
Sparks RS, Biggs J, Neuberg JW. Geophysics. Monitoring volcanoes. Science. 2012 Mar 16;335(6074):1310-1. doi: 10.1126/science.1219485. PMID: 22422969.
Copy Download .nbib Format: NLM
Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients.

Oncoimmunology

Brusic A, Hainz U, Wadleigh M, Neuberg D, Su M, Canning CM, Deangelo DJ, Stone RM, Lee JS, Mulligan RC, Ritz J, Dranoff G, Sasada T, Wu CJ.
PMID: 23170257
Oncoimmunology. 2012 Oct 01;1(7):1095-1103. doi: 10.4161/onci.20954.

BCR-ABL(+) K562 cells hold clinical promise as a component of cancer vaccines, either as bystander cells genetically modified to express immunostimulatory molecules, or as a source of leukemia antigens. To develop a method for detecting T-cell reactivity against K562...

Cite
Brusic A, Hainz U, Wadleigh M, et al. Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients. Oncoimmunology. 2012;1(7):1095-1103doi: 10.4161/onci.20954.
Brusic, A., Hainz, U., Wadleigh, M., Neuberg, D., Su, M., Canning, C. M., Deangelo, D. J., Stone, R. M., Lee, J. S., Mulligan, R. C., Ritz, J., Dranoff, G., Sasada, T., & Wu, C. J. (2012). Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients. Oncoimmunology, 1(7), 1095-1103. https://doi.org/10.4161/onci.20954
Brusic, Ana, et al. "Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients." Oncoimmunology vol. 1,7 (2012): 1095-1103. doi: https://doi.org/10.4161/onci.20954
Brusic A, Hainz U, Wadleigh M, Neuberg D, Su M, Canning CM, Deangelo DJ, Stone RM, Lee JS, Mulligan RC, Ritz J, Dranoff G, Sasada T, Wu CJ. Detecting T-cell reactivity to whole cell vaccines: Proof of concept analysis of T-cell response to K562 cell antigens in CML patients. Oncoimmunology. 2012 Oct 01;1(7):1095-1103. doi: 10.4161/onci.20954. PMID: 23170257; PMCID: PMC3494623.
Copy Download .nbib Format: NLM
Collective motion in selected central collisions of Au on Au at 150A MeV.

Physical review letters

Alard JP, Amouroux V, Basrak Z, Bastid N, Belayev IM, Berger L, Bini M, Blaich T, Boussange S, Buta A, Caplar R, Cerruti C, Cindro N, Coffin JP, Dona R, Dupieux P, Erö J, Fan ZG, Fintz P, Fodor Z, Fraysse L, Freifelder R, Frolov S, Gobbi A, Grigorian Y, Guillaume G, Herrmann N, Hildenbrand KD, Hölbling S, Houari A, Ibnouzahir M, Jeong SC, Jundt F, Kecskemeti J, Koncz P, Korchagin Y, Kotte R, Krämer M, Kuhn C, Lebedev A, Legrand I, Maguire C, Manko V, Maurenzig P, Mgebrishvili G, Moisa D, Montarou G, Montbel I, Morel P, Mösner J, Neubert W, Olmi A, Pasquali G, Pelte D, Petrovici M, Poggi G, Randrup J, Reisdorf W, Schüll D, Sodan U, Teh K, Trzaska M, Wessels JP, Wienold T.
PMID: 10056207
Phys Rev Lett. 1994 May 30;72(22):3468-3471. doi: 10.1103/PhysRevLett.72.3468.

No abstract available.

Cite
Alard JP, Amouroux V, Basrak Z, et al. Collective motion in selected central collisions of Au on Au at 150A MeV. Phys Rev Lett. 1994;72(22):3468-3471doi: 10.1103/PhysRevLett.72.3468.
Alard, J. P., Amouroux, V., Basrak, Z., Bastid, N., Belayev, I. M., Berger, L., Bini, M., Blaich, T., Boussange, S., Buta, A., Caplar, R., Cerruti, C., Cindro, N., Coffin, J. P., Dona, R., Dupieux, P., Erö, J., Fan, Z. G., Fintz, P., Fodor, Z., Fraysse, L., Freifelder, R., Frolov, S., Gobbi, A., Grigorian, Y., Guillaume, G., Herrmann, N., Hildenbrand, K. D., Hölbling, S., Houari, A., Ibnouzahir, M., Jeong, S. C., Jundt, F., Kecskemeti, J., Koncz, P., Korchagin, Y., Kotte, R., Krämer, M., Kuhn, C., Lebedev, A., Legrand, I., Maguire, C., Manko, V., Maurenzig, P., Mgebrishvili, G., Moisa, D., Montarou, G., Montbel, I., Morel, P., Mösner, J., Neubert, W., Olmi, A., Pasquali, G., Pelte, D., Petrovici, M., Poggi, G., Randrup, J., Reisdorf, W., Schüll, D., Sodan, U., Teh, K., Trzaska, M., Wessels, J. P., & Wienold, T. (1994). Collective motion in selected central collisions of Au on Au at 150A MeV. Physical review letters, 72(22), 3468-3471. https://doi.org/10.1103/PhysRevLett.72.3468
Alard, et al. "Collective motion in selected central collisions of Au on Au at 150A MeV." Physical review letters vol. 72,22 (1994): 3468-3471. doi: https://doi.org/10.1103/PhysRevLett.72.3468
Alard JP, Amouroux V, Basrak Z, Bastid N, Belayev IM, Berger L, Bini M, Blaich T, Boussange S, Buta A, Caplar R, Cerruti C, Cindro N, Coffin JP, Dona R, Dupieux P, Erö J, Fan ZG, Fintz P, Fodor Z, Fraysse L, Freifelder R, Frolov S, Gobbi A, Grigorian Y, Guillaume G, Herrmann N, Hildenbrand KD, Hölbling S, Houari A, Ibnouzahir M, Jeong SC, Jundt F, Kecskemeti J, Koncz P, Korchagin Y, Kotte R, Krämer M, Kuhn C, Lebedev A, Legrand I, Maguire C, Manko V, Maurenzig P, Mgebrishvili G, Moisa D, Montarou G, Montbel I, Morel P, Mösner J, Neubert W, Olmi A, Pasquali G, Pelte D, Petrovici M, Poggi G, Randrup J, Reisdorf W, Schüll D, Sodan U, Teh K, Trzaska M, Wessels JP, Wienold T. Collective motion in selected central collisions of Au on Au at 150A MeV. Phys Rev Lett. 1994 May 30;72(22):3468-3471. doi: 10.1103/PhysRevLett.72.3468. PMID: 10056207.
Copy Download .nbib Format: NLM
Depletion of light cluster production in 1 GeV proton-nucleus collisions.

Physical review. C, Nuclear physics

Andronenko LN, Kotov AA, Neubert W, Roepke G, Schulz H, Volnin EN.
PMID: 9952683
Phys Rev C Nucl Phys. 1985 Apr;31(4):1556-1559. doi: 10.1103/physrevc.31.1556.

No abstract available.

Cite
Andronenko LN, Kotov AA, Neubert W, et al. Depletion of light cluster production in 1 GeV proton-nucleus collisions. Phys Rev C Nucl Phys. 1985;31(4):1556-1559doi: 10.1103/physrevc.31.1556.
Andronenko, L. N., Kotov, A. A., Neubert, W., Roepke, G., Schulz, H., & Volnin, E. N. (1985). Depletion of light cluster production in 1 GeV proton-nucleus collisions. Physical review. C, Nuclear physics, 31(4), 1556-1559. https://doi.org/10.1103/physrevc.31.1556
Andronenko, et al. "Depletion of light cluster production in 1 GeV proton-nucleus collisions." Physical review. C, Nuclear physics vol. 31,4 (1985): 1556-1559. doi: https://doi.org/10.1103/physrevc.31.1556
Andronenko LN, Kotov AA, Neubert W, Roepke G, Schulz H, Volnin EN. Depletion of light cluster production in 1 GeV proton-nucleus collisions. Phys Rev C Nucl Phys. 1985 Apr;31(4):1556-1559. doi: 10.1103/physrevc.31.1556. PMID: 9952683.
Copy Download .nbib Format: NLM
Wrangling with P-values.

Pediatric blood & cancer

Neuberg D.
PMID: 28960684
Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26834. Epub 2017 Sep 27.

No abstract available.

Cite
Neuberg D. Wrangling with P-values. Pediatr Blood Cancer. 2017;65(1)doi: 10.1002/pbc.26834.
Neuberg, D. (2018). Wrangling with P-values. Pediatric blood & cancer, 65(1), . https://doi.org/10.1002/pbc.26834
Neuberg, Donna. "Wrangling with P-values." Pediatric blood & cancer vol. 65,1 (2018). doi: https://doi.org/10.1002/pbc.26834
Neuberg D. Wrangling with P-values. Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26834. Epub 2017 Sep 27. PMID: 28960684.
Copy Download .nbib Format: NLM
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities.

Blood advances

Morgan EA, Sweeney MP, Tomoka T, Kopp N, Gusenleitner D, Redd RA, Carey CD, Masamba L, Kamiza S, Pinkus GS, Neuberg DS, Rodig SJ, Milner DA, Weinstock DM.
PMID: 29296697
Blood Adv. 2016 Nov 22;1(1):84-92. doi: 10.1182/bloodadvances.2016000026. eCollection 2016 Nov 29.

Diagnostics and supportive care for patients with non-Hodgkin lymphoma (NHL) in lower- and middle-income countries (LMICs) are lacking. We hypothesized that high-throughput transcription-based diagnostics could classify NHL specimens from Malawi amenable to targeted therapeutics. We established tissue microarrays and...

Cite
Morgan EA, Sweeney MP, Tomoka T, et al. Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities. Blood Adv. 2016;1(1):84-92doi: 10.1182/bloodadvances.2016000026.
Morgan, E. A., Sweeney, M. P., Tomoka, T., Kopp, N., Gusenleitner, D., Redd, R. A., Carey, C. D., Masamba, L., Kamiza, S., Pinkus, G. S., Neuberg, D. S., Rodig, S. J., Milner, D. A., & Weinstock, D. M. (2016). Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities. Blood advances, 1(1), 84-92. https://doi.org/10.1182/bloodadvances.2016000026
Morgan, Elizabeth A, et al. "Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities." Blood advances vol. 1,1 (2016): 84-92. doi: https://doi.org/10.1182/bloodadvances.2016000026
Morgan EA, Sweeney MP, Tomoka T, Kopp N, Gusenleitner D, Redd RA, Carey CD, Masamba L, Kamiza S, Pinkus GS, Neuberg DS, Rodig SJ, Milner DA, Weinstock DM. Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities. Blood Adv. 2016 Nov 22;1(1):84-92. doi: 10.1182/bloodadvances.2016000026. eCollection 2016 Nov 29. PMID: 29296697; PMCID: PMC5744047.
Copy Download .nbib Format: NLM
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.

Blood advances

Field JJ, Majerus E, Gordeuk VR, Gowhari M, Hoppe C, Heeney MM, Achebe M, George A, Chu H, Sheehan B, Puligandla M, Neuberg D, Lin G, Linden J, Nathan DG.
PMID: 29296811
Blood Adv. 2017 Aug 28;1(20):1645-1649. doi: 10.1182/bloodadvances.2017009613. eCollection 2017 Sep 12.

Adenosine A

Cite
Field JJ, Majerus E, Gordeuk VR, et al. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood Adv. 2017;1(20):1645-1649doi: 10.1182/bloodadvances.2017009613.
Field, J. J., Majerus, E., Gordeuk, V. R., Gowhari, M., Hoppe, C., Heeney, M. M., Achebe, M., George, A., Chu, H., Sheehan, B., Puligandla, M., Neuberg, D., Lin, G., Linden, J., & Nathan, D. G. (2017). Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood advances, 1(20), 1645-1649. https://doi.org/10.1182/bloodadvances.2017009613
Field, Joshua J, et al. "Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease." Blood advances vol. 1,20 (2017): 1645-1649. doi: https://doi.org/10.1182/bloodadvances.2017009613
Field JJ, Majerus E, Gordeuk VR, Gowhari M, Hoppe C, Heeney MM, Achebe M, George A, Chu H, Sheehan B, Puligandla M, Neuberg D, Lin G, Linden J, Nathan DG. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease. Blood Adv. 2017 Aug 28;1(20):1645-1649. doi: 10.1182/bloodadvances.2017009613. eCollection 2017 Sep 12. PMID: 29296811; PMCID: PMC5728341.
Copy Download .nbib Format: NLM
Phonon spectra of pure and acceptor doped BaZrO.

Journal of physics. Condensed matter : an Institute of Physics journal

Mazzei L, Rukser D, Biebl F, Grimm-Lebsanft B, Neuber G, Pergolesi D, Börjesson L, Rübhausen MA, Andreasson J, Karlsson M.
PMID: 32628643
J Phys Condens Matter. 2020 Jul 06;32(40):405403. doi: 10.1088/1361-648X/ab95d1. Epub 2020 Jul 06.

We report results from visible and UV Raman spectroscopy studies of the phonon spectra of a polycrystalline sample of the prototypical perovskite type oxide BaZrO

Cite
Mazzei L, Rukser D, Biebl F, et al. Phonon spectra of pure and acceptor doped BaZrO. J Phys Condens Matter. 2020;32(40):405403doi: 10.1088/1361-648X/ab95d1.
Mazzei, L., Rukser, D., Biebl, F., Grimm-Lebsanft, B., Neuber, G., Pergolesi, D., Börjesson, L., Rübhausen, M. A., Andreasson, J., & Karlsson, M. (2020). Phonon spectra of pure and acceptor doped BaZrO. Journal of physics. Condensed matter : an Institute of Physics journal, 32(40), 405403. https://doi.org/10.1088/1361-648X/ab95d1
Mazzei, Laura, et al. "Phonon spectra of pure and acceptor doped BaZrO." Journal of physics. Condensed matter : an Institute of Physics journal vol. 32,40 (2020): 405403. doi: https://doi.org/10.1088/1361-648X/ab95d1
Mazzei L, Rukser D, Biebl F, Grimm-Lebsanft B, Neuber G, Pergolesi D, Börjesson L, Rübhausen MA, Andreasson J, Karlsson M. Phonon spectra of pure and acceptor doped BaZrO. J Phys Condens Matter. 2020 Jul 06;32(40):405403. doi: 10.1088/1361-648X/ab95d1. Epub 2020 Jul 06. PMID: 32628643.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 119 entries